...
首页> 外文期刊>Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices >Rapid and reagentless detection of thrombin in clinic samples via microfluidic aptasensors with multiple target-binding sites
【24h】

Rapid and reagentless detection of thrombin in clinic samples via microfluidic aptasensors with multiple target-binding sites

机译:通过具有多个靶结合位点的微流体Aptasensors的临床样品中的凝血酶在临床样品中的快速和无可测量检测

获取原文
获取原文并翻译 | 示例
           

摘要

A reusable and straightforward aptasensor with the implementation of open-ended porous silicon (OEPSi) membranes was introduced for thrombin detection. When passing through the nanochannels of OEPSi integrated in a microfluidic cell, thrombin in sample solution could be captured by thrombin-binding aptamers (TBA) immobilized along the inner walls. The formation of thrombin-aptamer complex causes refractive index changes which can be measured by reflective interferometric Fourier transform spectroscopy (RIFTS). And this flow-through configuration with OEPSi has proven more efficient in capturing thrombin than the flow-over configuration with closed-ended PSi. For higher sensitivity, we investigated how the pore size, ionic strength, pH and aptamers affected the thrombin-aptamer interaction in nanopores. Under optimized conditions, the limits of detection (LOD) for thrombin detection in the buffer and serum were similar to 6.70 nM and similar to 8.21 nM respectively and a wide linear detection range (10-1000 nM) was observed. More importantly, this work reveals the sensitivity of the label-free biosensor can be significantly improved by attaching newly designed aptamers with two thrombin-binding sites. This phenomenon also indicates the potential of aptamer probes in adjusting effective pore size and enhancing the interaction between aptamers and targets through meticulous sequence design. Furthermore, the proposed strategy has been applied in thrombin detection in clinic samples successfully, which was verified by Enzyme-Linked Immunosorbent Assays (ELISA).
机译:引入了具有开口结束多孔硅(OEPSI)膜的可重复使用和直接的Aptasentor用于凝血酶检测。当通过整合在微流体细胞中的OEPSI的纳米时,样品溶液中的凝血酶可以通过沿着内壁固定的凝血酶结合的适体(TBA)捕获。凝血酶 - 适体复合物的形成导致折射率变化,其可以通过反射干涉傅里叶变换光谱(RIFT)来测量。并且这种流通式配置在捕获血浆捕获而不是具有封闭端PSI的流动配置方面的效率更有效。为了更高的灵敏度,我们研究了孔径,离子强度,pH和适体如何影响纳米孔中的凝血酶 - 适体相互作用。在优化条件下,缓冲剂和血清中凝血酶检测的检测限率类似于6.70nm,并且类似于8.21nm,观察到宽的线性检测范围(10-1000nm)。更重要的是,这项工作揭示了通过用两个凝血酶结合位点附着新设计的适体来显着改善无标签的生物传感器的敏感性。这种现象还表明了适体探针在调节有效孔径和增强体内序列设计中的适应性和靶之间的相互作用的潜力。此外,所提出的策略已成功地应用于临床样品中的凝血酶检测,通过酶联免疫吸附测定(ELISA)验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号